title: [Is there a place for glucosamine in the community pharmacy?].
abstract: Glucosamine is a popular treatment for osteoarthritis. Despite of the ongoing debate around its efficiency, the sale of glucosamine is a success in pharmacies. The molecule remains issue of controversy: while some studies provide proof of its efficiency, other studies and meta-analysis are unable to answer the question or don't find any advantage. This article treats the current state of glucosamine regarding its efficiency and safety and aims to trigger the pharmacy-team to help the patient evaluating the product after three months of use.
authors.affiliation: Service Projets Scientifiques, CDSP- APB. joris.maesschalck@apb.be
authors.forename: J
authors.initials: J
authors.lastname: Maesschalck
mesh_terms: D001291:Attitude of Health Personnel; D002358:Cartilage, Articular / Q000473:pathology; D004345:Drug Industry; D004347:Drug Interactions; D005944:Glucosamine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010003:Osteoarthritis / Q000188:drug therapy* / Q000473:pathology; D010353:Patient Education as Topic; D010594:Pharmacies; D010595:Pharmacists
chemical_list: D005944:Glucosamine